Anthony Mato, MD, MSCE

CLL Program Director, Memorial Sloan Kettering Cancer Center

Dr. Anthony Mato is Director of the CLL Program at Memorial Sloan Kettering Cancer Center.

Programs Featuring Anthony Mato, MD, MSCE (9)

What's My Risk of COVID-19 Reinfection if I Have Antibodies?

Anthony Mato, MD, MSCE, Andrew Schorr

Should I Postpone CLL Treatment Due to COVID-19?

Anthony Mato, MD, MSCE, Andrew Schorr

COVID-19 Treatments in the News: What’s True?

Anthony Mato, MD, MSCE, Andrew Schorr

CLL and COVID-19: Do I Need to Stay Quarantined?

Anthony Mato, MD, MSCE, Andrew Schorr

New Study Shows COVID-19 Severity in CLL Patients

Anthony Mato, MD, MSCE, Andrew Schorr

Should I Get a COVID-19 Vaccine if I Have CLL?

Anthony Mato, MD, MSCE, Andrew Schorr

ASH CLL News 2018: Tools for Staying Up-to-Date on Research

Anthony Mato, MD, MSCE

Combination Therapy: Are Two Drugs More Effective to Combat CLL?

Anthony Mato, MD, MSCE, William Wierda, MD, PhD, Andrew Schorr

BTK Inhibitor Update From ASH 2017: What Are the Real-World Results?

Anthony Mato, MD, MSCE, Jennifer R. Brown, MD, PhD, Andrew Schorr